Ed-b fibronectin as stratification marker for anti-tumor drugs

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/18 (2006.01) C12N 5/09 (2010.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) A61K 51/10 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2698616

The present invention relates to a method for stratifying tumor cells comprising the steps:(a) providing a sample comprising tumor cells to be analysed, (b) contacting said sample with an ED-B fibronectin-specific molecule and assessing the binding thereof to tumor cells in said sample, and (c) stratifying said tumor cells based on the assessment of step (b).

La présente invention concerne un procédé permettant de stratifier des cellules tumorales consistant : (a) à se procurer un échantillon comportant des cellules tumorales devant être analysées, (b) à mettre en contact ledit échantillon avec une molécule spécifique de la fibronectine ED-B et à évaluer la liaison de celle-ci aux cellules tumorales dans ledit échantillon, et (c) à stratifier lesdites cellules tumorales sur la base de l'évaluation de l'étape (b).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ed-b fibronectin as stratification marker for anti-tumor drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ed-b fibronectin as stratification marker for anti-tumor drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ed-b fibronectin as stratification marker for anti-tumor drugs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1681232

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.